Walleye Capital LLC Seres Therapeutics, Inc. Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.93 - $2.15 $57,476 - $132,876	-61,803 Reduced 60.74%	39,948 $55,000
Q3 2023 Nov 14, 2023	BUY	$2.33 - $5.07 $237,079 - $515,877	101,751 New	101,751 $242,000
Q1 2023 May 15, 2023	BUY	$4.95 - $6.09 $1.75 Million - $2.16 Million	354,162 Added 4339.16%	362,324 $2.05 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $41,544 - $73,866	8,162 New	8,162 $45,000
Q2 2022 Aug 08, 2022	BUY	$2.7 - $7.62 $269,865 - $761,619	99,950 New	99,950 $343,000
Q4 2021 Mar 03, 2022	SELL	$6.02 - $11.43 $1.31 Million - $2.49 Million	-217,662 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $1.19 Million - $4.92 Million	217,662 New	217,662 $1.52 Million
Q3 2019 Nov 14, 2019	SELL	$2.29 - $4.16 $64,754 - $117,632	-28,277 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.28 - $7.35 $64,471 - $207,835	28,277 New	28,277 $91,000

46.7M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $102M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.